Fasikl’s Felix NeuroAI wristband is designed to provide noninvasive and non-pharmaceutical relief from essential tremor. The team received an ATMRD Poster Award after presenting the findings of a pilot study that showed the wristband provided all-day relief from essential tremor for 81.2 percent of assessed patients.
A research team from Fasikl — a start-up co-founded by Department of Biomedical Engineering Associate Professor Zhi Yang — recently received an Advanced Therapeutics in Movement & Related Disorders (ATMRD) Poster Award.
The team presented the findings of their initial pilot study of Fasikl’s noninvasive, non-pharmaceutical AI stimulation device for the treatment of essential tremor at the third annual ATMRD Congress held in Washington, D.C. Their poster was titled, “Pilot Study of the Felix NeuroAI Wristband in Patients with Essential Tremor.”
